Showing 7951-7960 of 8647 results for "".
- Optometry’s Meeting Cancelled Due to COVID-19https://modernod.com/news/optometrys-meeting-cancelled-due-to-covid-19/2477565/Out of an abundance of caution amid the ongoing COVID-19 pandemic, the American Optometric Association (AOA) has officially cancelled the annual Optometry’s Meeting, scheduled to take place on June 24-28 in Washington DC. The annual meeting of both the AOA and American Optometric Student As
- Contact Lens Institute Shares New CDC Guidance for Contact Lens Wear and COVID-19https://modernod.com/news/contact-lens-institute-shares-new-cdc-guidance-for-contact-lens-wear-and-covid-19/2477563/The Contact Lens Institute is sharing new guidance issued this week by the U.S. Centers for Disease Control and Prevention (CDC) regarding contact lens wear and care amid the COVID-19 pandemic. The direction,
- CMS Relaxes Rules to Boost Capacity of Providers as Facilities Tackle COVID-19 Outbreakhttps://modernod.com/news/cms-relaxes-rules-to-boost-capacity-of-providers-as-facilities-tackle-covid-19-outbreak/2477562/The Trump administration has relaxed rules to enable doctors to remotely care for patients across state lines at rural facilities and let nurse practitioners perform more duties as workforce capacity becomes a major concern, according to a FierceHealthcare
- Vazegepant, Investigational Drug Being Studied for Migraine, to Enter Phase 2 Trial for COVID-19 Treatmenthttps://modernod.com/news/vazegepant-investigational-drug-being-studied-for-migraine-to-enter-phase-2-trial-for-covid-19-treatment/2477557/The FDA has authorized initiation of a phase 2 trial of vazegepant (Biohaven, New Haven, CT) for potential treatment of COVID-19 pulmonary complications. Vazegepant is an intranasally delivered calcitonin gene-related peptide (CGRP) inhibitor antagonist in phase 3 trials for the treatment of migr
- Glaukos Provides Update on COVID-19 Impact and Preliminary Net Sales Range for First Quarterhttps://modernod.com/news/glaukos-provides-update-on-covid-19-impact-and-preliminary-net-sales-range-for-first-quarter/2477552/Glaukos provided an update on the impact of the COVID-19 pandemic on the company and announced a preliminary net sales range for its first quarter of 2020. Preliminary and Unaudited First Quarter 2020 Net Sales and COVID-19 Response Preliminary and unaudited net sales for the
- Gottlieb, Mostashari Propose National COVID-19 Surveillance Systemhttps://modernod.com/news/gottlieb-mostashari-propose-national-covid-19-surveillance-system/2477555/Five healthcare experts—including former top government healthcare officials Scott Gottlieb and Farzad Mostashari—have proposed a plan to build a national COVID-19 surveillance system, according to a FierceHealthcare
- Nicox Outlines Plans to Progress NCX 4251 into Phase 2b Trial Following Positive Meeting with FDAhttps://modernod.com/news/nicox-outlines-plans-to-progress-ncx-4251-into-phase-2b-trial-following-positive-meeting-with-fda/2477548/Nicox SA announced that it has held a Type C meeting with the FDA in which the data from the recently completed Danube phase 2 clinical trial of NCX 4251 was reviewed and the next NCX 4251 trial designs were discussed. Given the positive Danube phase 2 trial results in reduction of the signs and
- Icare USA Completes Merger with CenterVuehttps://modernod.com/news/icare-usa-completes-merger-with-centervue/2477549/Icare USA announced that it has completed its merger with CenterVue after the acquisition of CenterVue by Revenio Group Corporation in April 2019. Financial terms of the deal were not disclosed. In March 2020, the two corporations were consolidated under a single management team. Co
- Docs Push HHS to Offer Direct Funding as Finances Slump Due to COVID-19https://modernod.com/news/docs-push-hhs-to-offer-direct-funding-as-finances-slump-due-to-covid-19/2477545/Physicians are urging the Trump administration to provide a month’s worth of revenue to cover expenses as they’re stretched financially due to COVID-19, according to a FierceHealthcare
- Experts Provide Update on Medicare Waivers and Other Regulatory Provisions During COVID-19https://modernod.com/news/experts-provide-update-on-medicare-waivers-and-other-regulatory-provisions-during-covid-19/2479527/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, spoke with Allison Shuren, JD, MSN; Paul Rudolf, MD, JD; and Thomas Gustafson, PhD, to discuss a variety of regulatory topic